AstraZeneca In $5.3bn AI Drug Discovery Deal With China’s CSPC

2025-06-16 10:06

AstraZeneca to make upfront payment of $110m to China-based biotech CSPC in AI-driven deal to develop drugs for chronic health conditions

This article has been indexed from Silicon UK

Read the original article:

AstraZeneca In $5.3bn AI Drug Discovery Deal With China’s CSPC

Related

← Gemini, Coinbase Set To Receive EU Crypto Licences

Apple ‘Eyes Spring 2026’ For Delayed Siri AI Upgrade →